Bayan Takizawa, is a cofounder and Chief Business Officer at CONTINUUS Pharmaceuticals, where he leads business development and strategy activities. Dr. Takizawa has helped the CONTINUUS team raise over $90 million through financing rounds, grants, and contracts with multiple commercial partners and government agencies.
​
Most recently, Bayan led efforts to secure a $69.3M contract from the US Department of Defense to establish a first-of-its kind Integrated Continuous Manufacturing (ICM) facility in the United States. This manufacturing site will enable in-country production of critical drugs, such as those used in the treatment of Covid-19.
Before joining CONTINUUS, Bayan was a consultant at The Chartis Group, a leading advisory firm that provides strategic and operational support for hospitals and healthcare systems. Prior to Chartis, Bayan worked at Actin Biomed, a healthcare investment firm, and Yale New Haven Hospital as a General Surgery and Urology resident.
Bayan has an M.D. from Yale, an M.S. in Engineering Systems and M.B.A. from MIT, and a B.S. in Chemical Engineering from Cornell. He has multiple publications in peer-reviewed journals, and is an active member of the Massachusetts life sciences community.